Clinical Trials Logo
  1. Home
  2. Hip Arthroscopy
  3. NCT05076110
  4. Details
NCT05076110 Clinical Trial

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Hip Arthroscopy Clinical Trial

Official title:
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05076110
Other study ID # 21-003441
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date April 7, 2022
Est. completion date April 2025

Study information
Verified date June 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Recruitment information / eligibility
Status Recruiting
Enrollment 188
Est. completion date April 2025
Est. primary completion date April 2025
Accepts healthy volunteers No
Gender All
Age group 16 Years to 60 Years
Eligibility Inclusion Criteria: • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN) Exclusion Criteria: - medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin. - Substantial alcohol or drug abuse. - History of narcotics within 6 months of surgery. - Pregnancy. - Renal impairment. - Peptic ulcer disease. - GI bleeding.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Oxycodone
5 mg tablets every 4 hours postoperatively as needed for pain control
• Ibuprofen
800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day
• Gabapentin
300 mg three times a day for 5 days then wean off by day 10 postoperatively
• Acetaminophen
1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day
• Methocarbamol
500 mg three times a week for 2 weeks postoperatively

Locations
Country Name City State
United States Mayo clinic Rochester Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in pain score Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain Baseline, 14 days post-operatively
See also
  Status Clinical Trial Phase
Completed NCT03244631 - Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection N/A
Completed NCT01429805 - Balloon Assisted Hip Arthroscopy - Clinical Evaluation of a New Tool for Hip Arthroscopy N/A
Active, not recruiting NCT05592353 - Effect of Post-operative Brace on Pain and Patient Outcomes Following Hip Arthroscopy for FAIS N/A
Active, not recruiting NCT03909178 - Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum N/A
Active, not recruiting NCT03372564 - CREST: Capsular Repair During Hip Arthroscopy N/A
Completed NCT02882633 - Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy N/A
Completed NCT06082271 - Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy N/A
Recruiting NCT05402072 - AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip Phase 1
Recruiting NCT05746533 - An Evaluation of Hip Preservation Outcomes
Completed NCT04508504 - PENG Block for Arthroscopic Hip Surgery N/A
Enrolling by invitation NCT04516109 - Modifications of Devices for Hip Arthroscopy N/A
Completed NCT03510910 - Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy Phase 4